Filing Details
- Accession Number:
- 0001181431-13-019224
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-27 20:15:52
- Reporting Period:
- 2013-03-25
- Filing Date:
- 2013-03-27
- Accepted Time:
- 2013-03-27 20:15:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1373707 | Tetraphase Pharmaceuticals Inc | TTPH | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1164374 | Mediphase Venture Partners Ii Lp | 1 Gateway Center, Suite 407 Newton MA 02458 | No | No | Yes | No | |
| 1489776 | Partnership Limited Fund) (Select Ii Partners Venture Mediphase | 1 Gateway Center, Suite 407 Newton 02458 | No | No | Yes | No | |
| 1572286 | Anthony Paul Howard | 1 Gateway Center, Suite 407 Newton MA 02458 | No | No | Yes | No | |
| 1572287 | Partnership Limited Fund) (Annex Ii Partners Venture Mediphase | 1 Gateway Center, Suite 407 Newton MA 02458 | No | No | Yes | No | |
| 1572288 | Partnership Limited (Dp&Up) Partners Venture Mediphase | 1 Gateway Center, Suite 407 Newton MA 02458 | No | No | Yes | No | |
| 1572375 | Mediphase Ii (Annex Fund) Llc | 1 Gateway Center, Suite 407 Newton MA 02458 | No | No | Yes | No | |
| 1572377 | Mediphase (Dp&Up) Llc | 1 Gateway Center, Suite 407 Newton MA 02458 | No | No | Yes | No | |
| 1572378 | G. Lawrence Miller | 1 Gateway Center, Suite 407 Newton MA 02458 | No | No | Yes | No | |
| 1572379 | Mediphase Ii Llc | 1 Gateway Center, Suite 407 Newton MA 02458 | No | No | Yes | No | |
| 1572439 | Mediphase Ii (Select Fund) Llc | 1 Gateway Center, Suite 407 Newton MA 02458 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-03-25 | 13,793 | $0.00 | 13,793 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-03-25 | 13,793 | $0.00 | 28,160 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-03-25 | 27,586 | $0.00 | 56,321 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-03-25 | 17,991 | $0.00 | 31,784 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-03-25 | 17,991 | $0.00 | 46,151 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-03-25 | 35,982 | $0.00 | 92,303 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-03-25 | 73,535 | $0.00 | 105,319 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-03-25 | 106,776 | $0.00 | 152,927 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-03-25 | 213,552 | $0.00 | 305,855 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-03-25 | 313,845 | $0.00 | 419,164 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-03-25 | 95,226 | $0.00 | 248,153 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-03-25 | 295,068 | $0.00 | 600,923 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-03-25 | 100,591 | $0.00 | 100,591 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2013-03-25 | 164,285 | $7.00 | 765,208 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2013-03-25 | 121,428 | $7.00 | 540,592 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | C | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A-1 Convertible Participating Preferred Stock | Disposition | 2013-03-25 | 400,000 | $0.00 | 13,793 | $0.00 |
| Common Stock | Series A-1 Convertible Participating Preferred Stock | Disposition | 2013-03-25 | 400,000 | $0.00 | 13,793 | $0.00 |
| Common Stock | Series A-1 Convertible Participating Preferred Stock | Disposition | 2013-03-25 | 800,000 | $0.00 | 27,586 | $0.00 |
| Common Stock | Series A-2 Convertible Participating Preferred Stock | Disposition | 2013-03-25 | 521,739 | $0.00 | 17,991 | $0.00 |
| Common Stock | Series A-2 Convertible Participating Preferred Stock | Disposition | 2013-03-25 | 521,739 | $0.00 | 17,991 | $0.00 |
| Common Stock | Series A-2 Convertible Participating Preferred Stock | Disposition | 2013-03-25 | 1,043,478 | $0.00 | 35,982 | $0.00 |
| Common Stock | Series B Convertible Participating Preferred Stock | Disposition | 2013-03-25 | 2,132,517 | $0.00 | 73,555 | $0.00 |
| Common Stock | Series B Convertible Participating Preferred Stock | Disposition | 2013-03-25 | 3,096,509 | $0.00 | 106,776 | $0.00 |
| Common Stock | Series B Convertible Participating Preferred Stock | Disposition | 2013-03-25 | 6,193,019 | $0.00 | 213,552 | $0.00 |
| Common Stock | Series C Convertible Participating Preferred Stock | Disposition | 2013-03-25 | 9,101,517 | $0.00 | 313,845 | $0.00 |
| Common Stock | Series C Convertible Participating Preferred Stock | Disposition | 2013-03-25 | 2,761,571 | $0.00 | 95,226 | $0.00 |
| Common Stock | Series C Convertible Participating Preferred Stock | Disposition | 2013-03-25 | 8,556,982 | $0.00 | 295,068 | $0.00 |
| Common Stock | Series C Convertible Participating Preferred Stock | Disposition | 2013-03-25 | 2,917,152 | $0.00 | 100,591 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The Series A-1, Series A-2, Series B and Series C Convertible Preferred Stock converted into Common Stock on a 1-for-29 basis upon the closing of the issuer's initial public offering without payment of consideration.
- These securities are held solely by Mediphase Venture Partners (DP & UP) Limited Partnership. Mediphase Venture Partners (DP & UP) LLC is the general partner of Mediphase Venture Partners (DP & UP) Limited Partnership. The members of Mediphase(DP & UP) LLC are Lawrence Miller and Paul Howard. Mediphase(DP & UP) LLC and each of these individuals exercises shared voting and investment power over the shares held of record by Mediphase Venture Partners (DP & UP) Limited Partnership. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- These securities are held solely by Mediphase Venture Partners II (Annex Fund) Limited Partnership. Mediphase II (Annex Fund) LLC is the general partner of Mediphase Venture Partners II (Annex Fund) Limited Partnership. The members of Mediphase II (Annex Fund) LLC are Lawrence Miller and Paul Howard. Mediphase II (Annex Fund) LLC and each of these individuals exercises shared voting and investment power over the shares held of record by Mediphase Venture Partners II (Annex Fund) Limited Partnership. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- These securities are held solely by Mediphase Venture Partners II Limited Partnership. Mediphase II LLC is the general partner of Mediphase Venture Partners II Limited Partnership. The members of Mediphase II LLC are Lawrence Miller and Paul Howard. Mediphase II LLC and each of these individuals exercises shared voting and investment power over the shares held of record by Mediphase Venture Partners II Limited Partnership. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- These securities are held solely by Mediphase II (Select Fund) Limited Partnership. Mediphase II (Select Fund) LLC is the general partner of Mediphase Venture Partners II (Select Fund) L.P. The members of Mediphase II (Select Fund) LLC are Lawrence Miller and Paul Howard. Mediphase II (Select Fund) LLC and each of these individuals exercises shared voting and investment power over the shares held of record by Mediphase Venture Partners II (Select Fund) L.P. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of any pecuniary interest therein.
- Not Applicable
Billionaire Hedge Funds
